BP
The startup develops genome editing technology that enables the cultivation of bacteria to modify and control microbiomes for therapeutic applications. This approach allows researchers to conduct precise gene editing and microbiome engineering, facilitating the development of targeted treatments for various health conditions.
Updated 18 months ago
Funding
$19.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ERFunding rounds are not available yet.
Founders
Product
Features
- The startup develops genome editing technology that enables the cultivation of bacteria to modify and control microbiomes for therapeutic applications. This approach allows researchers to conduct precise gene editing and microbiome engineering, facilitating the development of targeted treatments for various health conditions.